title: Updates on prevention: obesity, ezetimibe, PCSK9, and HIV infection.
authors.affiliation: Editor-in-Chief, Zurich Heart House, Careum Campus, Moussonstrasse 4, 8091 Zurich, Switzerland.
authors.forename: Thomas F
authors.initials: TF
authors.lastname: Lüscher
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D015992:Body Mass Index; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control*; D008078:Cholesterol, LDL / Q000097:blood; D000069438:Ezetimibe / Q000627:therapeutic use; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D006937:Hypercholesterolemia; D006950:Hyperlipidemia, Familial Combined / Q000188:drug therapy; D009765:Obesity / Q000150:complications / Q000175:diagnosis / Q000517:prevention & control*; D000091362:PCSK9 Inhibitors; D013739:Testosterone / Q000097:blood; D000071449:Proprotein Convertase 9
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL; D000069438:Ezetimibe; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000091362:PCSK9 Inhibitors; D013739:Testosterone; C472125:PCSK9 protein, human; D000071449:Proprotein Convertase 9; C571059:alirocumab